In contrast, NETosis inhibitor GSK484 and PAD4 knock-out had no effect on the development of thrombocytopenia (Fig. 4e) although they strongly inhibited thrombosis (Fig. 4a, b). This evidence concerns the gene PADI4 and Thrombocytopenia.